These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16931516)

  • 1. Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase.
    Reinert RB; Oberle LM; Wek SA; Bunpo P; Wang XP; Mileva I; Goodwin LO; Aldrich CJ; Durden DL; McNurlan MA; Wek RC; Anthony TG
    J Biol Chem; 2006 Oct; 281(42):31222-33. PubMed ID: 16931516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase.
    Bunpo P; Dudley A; Cundiff JK; Cavener DR; Wek RC; Anthony TG
    J Biol Chem; 2009 Nov; 284(47):32742-9. PubMed ID: 19783659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment.
    Wilson GJ; Bunpo P; Cundiff JK; Wek RC; Anthony TG
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1124-33. PubMed ID: 24002574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.
    Nguyen HA; Durden DL; Lavie A
    Sci Rep; 2017 Jan; 7():41643. PubMed ID: 28139703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS; Tang E; Dolowy WC
    Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-resolved analysis of amino acid stress identifies eIF2 phosphorylation as necessary to inhibit mTORC1 activity in liver.
    Nikonorova IA; Mirek ET; Signore CC; Goudie MP; Wek RC; Anthony TG
    J Biol Chem; 2018 Apr; 293(14):5005-5015. PubMed ID: 29449374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-induced asparagine and glutamine depletion and immune system function.
    Kafkewitz D; Bendich A
    Am J Clin Nutr; 1983 Jun; 37(6):1025-30. PubMed ID: 6342356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.
    Bunpo P; Cundiff JK; Reinert RB; Wek RC; Aldrich CJ; Anthony TG
    J Nutr; 2010 Nov; 140(11):2020-7. PubMed ID: 20861212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of L-asparaginase in childhood ALL.
    Müller HJ; Boos J
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General control nonderepressible 2 deletion predisposes to asparaginase-associated pancreatitis in mice.
    Phillipson-Weiner L; Mirek ET; Wang Y; McAuliffe WG; Wek RC; Anthony TG
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1061-70. PubMed ID: 26968207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells.
    Broome JD
    J Exp Med; 1968 Jun; 127(6):1055-72. PubMed ID: 4871211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alanyl-glutamine consumption modifies the suppressive effect of L-asparaginase on lymphocyte populations in mice.
    Bunpo P; Murray B; Cundiff J; Brizius E; Aldrich CJ; Anthony TG
    J Nutr; 2008 Feb; 138(2):338-43. PubMed ID: 18203901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review.
    Sindhu R; Manonmani HK
    Anticancer Agents Med Chem; 2022; 22(13):2393-2410. PubMed ID: 34994334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.
    Wilson GJ; Lennox BA; She P; Mirek ET; Al Baghdadi RJ; Fusakio ME; Dixon JL; Henderson GC; Wek RC; Anthony TG
    Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E283-93. PubMed ID: 25491724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes.
    Sannikova EP; Bulushova NV; Cheperegin SE; Gubaydullin II; Chestukhina GG; Ryabichenko VV; Zalunin IA; Kotlova EK; Konstantinova GE; Kubasova TS; Shtil AA; Pokrovsky VS; Yarotsky SV; Efremov BD; Kozlov DG
    Mol Biotechnol; 2016 Sep; 58(8-9):528-39. PubMed ID: 27198565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of liver protein synthesis during dietary leucine deprivation occurs at the expense of skeletal muscle mass in mice deleted for eIF2 kinase GCN2.
    Anthony TG; McDaniel BJ; Byerley RL; McGrath BC; Cavener DR; McNurlan MA; Wek RC
    J Biol Chem; 2004 Aug; 279(35):36553-61. PubMed ID: 15213227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of blastogenesis by native and polyethylene glycol-modified asparaginases from Escherichia coli and Vibrio succinogenes.
    Bendich A; Kafkewitz D; Abuchowski A; Davis FF
    Immunol Commun; 1983; 12(3):273-84. PubMed ID: 6350165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Asparaginase inhibits the rapamycin-targeted signaling pathway.
    Iiboshi Y; Papst PJ; Hunger SP; Terada N
    Biochem Biophys Res Commun; 1999 Jul; 260(2):534-9. PubMed ID: 10403802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
    Avramis VI; Panosyan EH
    Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
    Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.